{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:17:18Z","timestamp":1787977038505,"version":"build-2784847793"},"reference-count":40,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,8,25]]},"DOI":"10.1248\/bpb.b26-00285","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:14:02Z","timestamp":1787609642000},"page":"1291-1297","source":"Crossref","is-referenced-by-count":0,"title":["Dosing Time-Dependent Anti-arthritic Effects of Peficitinib in Collagen-Induced Arthritis Rats"],"prefix":"10.1248","volume":"49","author":[{"given":"Hideto","family":"To","sequence":"first","affiliation":[{"name":"Department of Medical Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"},{"name":"Toyama Community Medicine &amp; Laboratory, 40\u20131 Akai, Imizu, Toyama 939\u20130287, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gabriel SE. The epidemiology of rheumatoid arthritis. <i>Rheum. Dis. Clin. North Am.<\/i>, <b>27<\/b>, 269\u2013281 (2001).","DOI":"10.1016\/S0889-857X(05)70201-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Srivastava S, Rasool M. Genetics, epigenetics and autoimmunity constitute a Bermuda triangle for the pathogenesis of rheumatoid arthritis. <i>Life Sci.<\/i>, <b>357<\/b>, 123075 (2024).","DOI":"10.1016\/j.lfs.2024.123075"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bellamy N, Sothern RB, Campbell J, Buchanan WW. Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. <i>Ann. Rheum. Dis.<\/i>, <b>50<\/b>, 243\u2013248 (1991).","DOI":"10.1136\/ard.50.4.243"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kowanko IC, Knapp MS, Pownall R, Swannell AJ. Domiciliary self-measurement in the rheumatoid arthritis and the demonstration of circadian rhythmicity. <i>Ann. Rheum. Dis.<\/i>, <b>41<\/b>, 453\u2013455 (1982).","DOI":"10.1136\/ard.41.5.453"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. <i>Ann. Rheum. Dis.<\/i>, <b>61<\/b>, 1075\u20131080 (2002).","DOI":"10.1136\/ard.61.12.1075"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Duffy JF, Dijk DJ, Klerman EB, Czeisler CA. Later endogenous circadian temperature nadir relative to an earlier wake time in older people. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.<\/i>, <b>275<\/b>, R1478\u2013R1487 (1998).","DOI":"10.1152\/ajpregu.1998.275.5.R1478"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Chan S, Debono M. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy. <i>Ther. Adv. Endocrinol. Metab.<\/i>, <b>1<\/b>, 129\u2013138 (2010).","DOI":"10.1177\/2042018810380214"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. <i>Ann. Rheum. Dis.<\/i>, <b>68<\/b>, 63\u201368 (2009).","DOI":"10.1136\/ard.2007.086561"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bruguerolle B, Labrecque G. Rhythmic pattern in pain and their chronotherapy. <i>Adv. Drug Deliv. Rev.<\/i>, <b>59<\/b>, 883\u2013895 (2007).","DOI":"10.1016\/j.addr.2006.06.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, Haus EL. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. <i>Sleep Med. Rev.<\/i>, <b>21<\/b>, 12\u201322 (2015).","DOI":"10.1016\/j.smrv.2014.06.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Burioka N, Fukuoka Y, Koyanagi S, Miyata M, Takata M, Chikumi H, Takane H, Watanabe M, Endo M, Sako T, Suyama H, Ohdo S, Shimizu E. Asthma: chronopharmacotherapy and the molecular clock. <i>Adv. Drug Deliv. Rev.<\/i>, <b>62<\/b>, 946\u2013955 (2010).","DOI":"10.1016\/j.addr.2010.03.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Durrington HJ, Farrow SN, Loudon AS, Ray DW. The circadian clock and asthma. <i>Thorax<\/i>, <b>69<\/b>, 90\u201392 (2014).","DOI":"10.1136\/thoraxjnl-2013-203482"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Cutolo M, Seriolo B, Craviotto C, Pizzorni C, Sulli A. Circadian rhythms in RA. <i>Ann. Rheum. Dis.<\/i>, <b>62<\/b>, 593\u2013596 (2003).","DOI":"10.1136\/ard.62.7.593"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Cutolo M, Otsa K, Aakre O, Sulli A. Nocturnal hormones and clinical rhythms in rheumatoid arthritis. <i>Ann. N. Y. Acad. Sci.<\/i>, <b>1051<\/b>, 372\u2013381 (2005).","DOI":"10.1196\/annals.1361.079"},{"key":"15","unstructured":"15) Herold M, G\u00fcnther R. Circadian rhythm of C-reactive protein in patients with rheumatoid arthritis. <i>Prog. Clin. Biol. Res.<\/i>, <b>227B<\/b>, 271\u2013279 (1987). \u2039https:\/\/europepmc.org\/article\/med\/3628337\u203a."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yoshimatsu H, Okazaki F, Ieiri I, To H. Mechanism of the 24-hour rhythm of tumor necrosis factor-alpha formed by onset of rheumatoid arthritis. <i>Chronobiol. Int.<\/i>, <b>31<\/b>, 564\u2013571 (2014).","DOI":"10.3109\/07420528.2013.878350"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) To H, Irie S, Tomonari M, Watanabe Y, Kitahara T, Sasaki H. Therapeutic index of methotrexate depends on circadian cycling of tumour necrosis factor-alpha in collagen-induced arthritic rats and mice. <i>J. Pharm. Pharmacol.<\/i>, <b>61<\/b>, 1333\u20131338 (2009).","DOI":"10.1211\/jpp\/61.10.0009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, Sonemoto E, Shimasaki N, Koyanagi S, Sasaki H, Ieiri I, Higuchi S, Kawakami A, Ueki Y, Eguchi K. Methotrexate chronotherapy is effective against rheumatoid arthritis. <i>Chronobiol. Int.<\/i>, <b>28<\/b>, 267\u2013274 (2011).","DOI":"10.3109\/07420528.2011.553017"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kanasaki Y, Tomonari M, Sasaki H, To H. Chronopharmacology of mizoribine in collagen-induced arthritis rats. <i>J. Pharmacol. Sci.<\/i>, <b>120<\/b>, 112\u2013120 (2012).","DOI":"10.1254\/jphs.12059FP"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Obayashi K, Tomonari M, Yoshimatsu H, Fukuyama R, Ieiri I, Higuchi S, To H. Dosing time-dependency of the arthritis-inhibiting effect of tacrolimus in mice. <i>J. Pharmacol. Sci.<\/i>, <b>116<\/b>, 264\u2013273 (2011).","DOI":"10.1254\/jphs.11029FP"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Yamaoka K, Saharinen P, Pesu M, Holt VE 3rd, Silvennoinen O, O\u2019Shea JJ. The Janus kinases (Jaks). <i>Genome Biol.<\/i>, <b>5<\/b>, 253 (2004).","DOI":"10.1186\/gb-2004-5-12-253"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) O\u2019Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. <i>N. Engl. J. Med.<\/i>, <b>368<\/b>, 161\u2013170 (2013).","DOI":"10.1056\/NEJMra1202117"},{"key":"23","unstructured":"23) Hodge JA, Kawabata TT, Krishnaswami S, Clark JD, Telliez JB, Dowty ME, Menon S, Lamba M, Zwillich S. The mechanism of action of tofacitinib\u2014an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. <i>Clin. Exp. Rheumatol.<\/i>, <b>34<\/b>, tm318\u2013328 (2016)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kang S, Tanaka T, Kishimoto T. Therapeutic uses of anti-interleukin-6 receptor antibody. <i>Int. Immunol.<\/i>, <b>27<\/b>, 21\u201329 (2015).","DOI":"10.1093\/intimm\/dxu081"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Meroni PL, Valesini G. Tumour necrosis factor \u03b1 antagonists in the treatment of rheumatoid arthritis: an immunological perspective. <i>BioDrugs<\/i>, <b>28<\/b>(Suppl 1), 5\u201313 (2014).","DOI":"10.1007\/s40259-013-0063-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Burmester GR, Blanco R, Charles-Schoeman C, Wollenhaupt J, Zerbini C, Benda B, Gruben D, Wallenstein G, Krishnaswami S, Zwillich SH, Koncz T, Soma K, Bradley J, Mebus C. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomized phase 3 trial. <i>Lancet<\/i>, <b>381<\/b>, 451\u2013460 (2013).","DOI":"10.1016\/S0140-6736(12)61424-X"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Genovese MC, Kremer J, Zamani O, Ludivico C, Krogulec M, Xie L, Beattie SD, Koch AE, Cardillo TE, Rooney TP, Macias WL, de Bono S, Schlichting DE, Smolen JS. Baricitinib in patients with refractory rheumatoid arthritis. <i>N. Engl. J. Med.<\/i>, <b>374<\/b>, 1243\u20131252 (2016).","DOI":"10.1056\/NEJMoa1507247"},{"key":"28","unstructured":"28) Akiyama S, To H. Dosing time-dependency of the arthritis-inhibiting effect of tofacitinib in mice. <i>J. Pharm. Drug Dev<\/i>, <b>11<\/b> (2024)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Markham A, Keam SJ. Peficitinib: first global approval. <i>Drugs<\/i>, <b>79<\/b>, 887\u2013891 (2019).","DOI":"10.1007\/s40265-019-01131-y"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kaneko Y. Efficacy and safety of peficitinib in rheumatoid arthritis. <i>Mod. Rheumatol.<\/i>, <b>30<\/b>, 773\u2013778 (2020).","DOI":"10.1080\/14397595.2020.1794103"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kivitz AJ, Gutierrez-Ure\u00f1a SR, Poiley J, Genovese MC, Kristy R, Shay K, Wang X, Garg JP, Zubrzycka-Sienkiewicz A. Peficitinib, a JAK inhibitor, in the treatment of moderate-to-severe rheumatoid arthritis in patients with an inadequate response to methotrexate. <i>Arthritis Rheumatol.<\/i>, <b>69<\/b>, 709\u2013719 (2017).","DOI":"10.1002\/art.39955"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Meng HC, Griffiths MM, Remmers EF, Kawahito Y, Li W, Neisa R, Cannon GW, Wilder RL, Gulko PS. Identification of two novel female-specific non-major histocompatibility complex loci regulating collagen-induced arthritis severity and chronicity, and evidence of epistasis. <i>Arthritis Rheum.<\/i>, <b>50<\/b>, 2695\u20132705 (2004).","DOI":"10.1002\/art.20366"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Wooley PH, Luthra HS, Krco CJ, Stuart JM, David CS. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. <i>Arthritis Rheum.<\/i>, <b>27<\/b>, 1010\u20131017 (1984).","DOI":"10.1002\/art.1780270907"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Holmdahl R, Andersson ME, Goldschmidt TJ, Jansson L, Karlsson M, Malmstr\u00f6m V, Mo J. Collagen induced arthritis as an experimental model for rheumatoid arthritis: immunogenetics, pathogenesis and autoimmunity. <i>APMIS<\/i>, <b>97<\/b>, 575\u2013584 (1989).","DOI":"10.1111\/j.1699-0463.1989.tb00446.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Arvidson NG, Gudbj\u00f6rnsson B, Elfman L, Ryd\u00e9n AC, T\u00f6tterman TH, H\u00e4llgren R. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. <i>Ann. Rheum. Dis.<\/i>, <b>53<\/b>, 521\u2013524 (1994).","DOI":"10.1136\/ard.53.8.521"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C, Briata M, Seriolo B, Cutolo M. Melatonin serum levels in rheumatoid arthritis. <i>Ann. N. Y. Acad. Sci.<\/i>, <b>966<\/b>, 276\u2013283 (2002).","DOI":"10.1111\/j.1749-6632.2002.tb04227.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Clench J, Reinberg A, Dziewanowska Z, Ghata J, Smolensky M. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. <i>Eur. J. Clin. Pharmacol.<\/i>, <b>20<\/b>, 359\u2013369 (1981).","DOI":"10.1007\/BF00615406"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Cao QR, Kim TW, Choi JS, Lee BJ. Circadian variations in the pharmacokinetics, tissue distribution and urinary excretion of nifedipine after a single oral administration to rats. <i>Biopharm. Drug Dispos.<\/i>, <b>26<\/b>, 427\u2013437 (2005).","DOI":"10.1002\/bdd.474"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ch\u00e2teauvert N, C\u00f4t\u00e9 H. Circadian variations in the pharmacokinetics of a new microemulsion formulation of cyclosporine in cardiac transplant recipients. <i>Pharmacotherapy<\/i>, <b>18<\/b>, 364\u2013370 (1998).","DOI":"10.1002\/j.1875-9114.1998.tb03863.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Seto Y, Yoshihashi T, Tomonari M, To H. Absorption of glucosamine is improved by considering circadian rhythm and feeding time in rats. <i>Chronobiol. Int.<\/i>, <b>37<\/b>, 1528\u20131537 (2020).","DOI":"10.1080\/07420528.2020.1784189"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00285\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:28:13Z","timestamp":1787974093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00285\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00285","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"b26-00285"}}